FDA launches pilot program to improve US generic drug manufacturingnews2025-10-06T15:43:57+00:00October 6th, 2025|Endpoints News|
Legal pressure builds around FDA’s new DTC pharma ad crackdownnews2025-10-03T18:51:43+00:00October 3rd, 2025|Endpoints News|
New protections could shield blockbusters from Medicare negotiations — expertsnews2025-10-02T19:30:08+00:00October 2nd, 2025|Endpoints News|
Vanda ends lawsuits against FDA as part of wide-ranging agreement with agencynews2025-10-02T18:37:35+00:00October 2nd, 2025|Endpoints News|
Ousted NIAID director says she objected to RFK Jr.’s ‘unscientific hostility’ to vaccinesnews2025-10-02T18:15:48+00:00October 2nd, 2025|Endpoints News|
Despite shutdown, companies still plan to submit upcoming FDA applicationsnews2025-10-02T15:21:14+00:00October 2nd, 2025|Endpoints News|
Third-round IRA guidance spells out new orphan drug protectionsnews2025-10-01T20:00:21+00:00October 1st, 2025|Endpoints News|
FDA rejects treatment for rare copper deficiency over manufacturingnews2025-10-01T13:17:23+00:00October 1st, 2025|Endpoints News|
FDA approves Novartis’ BTK inhibitor for chronic hivesnews2025-09-30T20:57:00+00:00September 30th, 2025|Endpoints News|
‘Likely’ government shutdown threatens to stress an already depleted FDAnews2025-09-30T18:28:30+00:00September 30th, 2025|Endpoints News|
